Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests

Overview of attention for article published in BMC Infectious Diseases, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 12 news outlets
policy: 1 policy source

twitter: 1 tweeter

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 34 Mendeley

Summary News Policy documents Twitter Dimensions citations

So far, Altmetric has seen 12 news stories from 12 outlets.

News story from Finanz Nachrichten on Thursday 05 August 2021

Finanz Nachrichten, 05 Aug 2021

Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.

Spoke, 04 Aug 2021

"Because Prevention is Possible" KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device…

Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.

PR Newswire UK, 04 Aug 2021

"Because Prevention is Possible" KLOKKARSTUA,, /PRNewswire/ -- Mel-Mont Medical, a boutique medical device and technology…

Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.

Yahoo!, 04 Aug 2021

"Because Prevention is Possible" KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 8 additional news stories.